Allianz Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,500
| Closed | -$258K | – | 1828 |
|
|
2024
Q4 | $258K | Hold |
19,500
| – | – | ﹤0.01% | 1571 |
|
|
2024
Q3 | $375K | Sell |
19,500
-10,800
| -36% | -$208K | ﹤0.01% | 1482 |
|
|
2024
Q2 | $622K | Hold |
30,300
| – | – | ﹤0.01% | 1362 |
|
|
2024
Q1 | $721K | Sell |
30,300
-700
| -2% | -$16.7K | ﹤0.01% | 1324 |
|
|
2023
Q4 | $670K | Buy |
+31,000
| New | +$670K | ﹤0.01% | 1330 |
|
|
2023
Q3 | – | Sell |
-26,800
| Closed | -$561K | – | 1728 |
|
|
2023
Q2 | $561K | Buy |
26,800
+6,800
| +34% | +$142K | ﹤0.01% | 1281 |
|
|
2023
Q1 | $422K | Buy |
20,000
+4,000
| +25% | +$84.5K | ﹤0.01% | 1457 |
|
|
2022
Q4 | $407K | Hold |
16,000
| – | – | ﹤0.01% | 1386 |
|
|
2022
Q3 | $384K | Sell |
16,000
-92,655
| -85% | -$2.22M | ﹤0.01% | 1349 |
|
|
2022
Q2 | $2.09M | Buy |
108,655
+9,145
| +9% | +$176K | ﹤0.01% | 1290 |
|
|
2022
Q1 | $1.73M | Buy |
99,510
+25,280
| +34% | +$439K | ﹤0.01% | 1403 |
|
|
2021
Q4 | $1.62M | Buy |
+74,230
| New | +$1.62M | ﹤0.01% | 1462 |
|